146 related articles for article (PubMed ID: 19863208)
1. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure.
Nemoto T; Imai C; Kaneko U; Takachi T; Iwabuchi H; Tanaka A; Nakamura G; Ogose A; Uchiyama M
Pediatr Hematol Oncol; 2009; 26(7):520-5. PubMed ID: 19863208
[TBL] [Abstract][Full Text] [Related]
2. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
[TBL] [Abstract][Full Text] [Related]
3. Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.
Chan WK; Hui WF
Pediatr Nephrol; 2016 Oct; 31(10):1699-703. PubMed ID: 27335061
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
5. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
7. Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion.
Relling MV; Stapleton FB; Ochs J; Jones DP; Meyer W; Wainer IW; Crom WR; McKay CP; Evans WE
Cancer; 1988 Sep; 62(5):884-8. PubMed ID: 3261621
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
9. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
[TBL] [Abstract][Full Text] [Related]
11. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
[TBL] [Abstract][Full Text] [Related]
12. Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency.
Molina R; Fabian C; Cowley B
Am J Med; 1987 Feb; 82(2):350-2. PubMed ID: 3812535
[TBL] [Abstract][Full Text] [Related]
13. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
14. Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.
Escobosa Sánchez OM; Herrero Hernández A; Ortega Acosta MJ; Camacho Alonso J; Milano Manso G; Acha García T
Clin Transl Oncol; 2006 May; 8(5):379-80. PubMed ID: 16760016
[No Abstract] [Full Text] [Related]
15. Methotrexate poisoning with acute hepatorenal dysfunction.
Goto E; Tomojiri S; Okamoto I; Tanaka K
J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
[TBL] [Abstract][Full Text] [Related]
16. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
Al-Turkmani MR; Law T; Narla A; Kellogg MD
Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
[No Abstract] [Full Text] [Related]
17. Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Shinozaki T; Watanabe H; Tomidokoro R; Yamamoto K; Horiuchi R; Takagishi K
Med Pediatr Oncol; 2000 Mar; 34(3):226-8. PubMed ID: 10696135
[No Abstract] [Full Text] [Related]
18. [High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis].
Brain E; Alexandre J; Minozzi C; Misset JL
Presse Med; 1997 Mar; 26(6):265-8. PubMed ID: 9122123
[TBL] [Abstract][Full Text] [Related]
19. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
[TBL] [Abstract][Full Text] [Related]
20. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
Ozguven AA; Uysal K; Gunes D; Koroglu T; Gurcu O; Olgun N
J Pediatr Hematol Oncol; 2009 Apr; 31(4):289-91. PubMed ID: 19346884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]